Sight Sciences, Inc. SGHT 深 沪
已收盘 04-02 16:00:00 美东时间
3.52
-0.140
-3.83%
华盛通- 最 高3.61
- 今 开3.61
- 成交量 23.66万股
- 最 低 3.4101
- 昨 收 3.66
- 总市值 1.90亿
- 52周最高 9.2362
- 市盈率 静 --
- 换手率 0.44%
- 52周最低 2.30
- 委 比 49.59%
- 总股本 5400.60万
- 历史最高 42.57
- 量 比 0.65
- 振 幅 5.46%
- 历史最低 1.04
- 每 手 1
- 风险率 1.74%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多U.S. District Court Preserves Jury's Willful Infringement Verdict In Sight Sciences Case Vs Alcon
Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve
03-30 19:09
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
Sight Sciences shares are trading lower after the company reported worse-than-expected Q4 sales results.
Sight Sciences shares are trading lower after the company reported worse-than-e...
03-06 00:01
Sight Sciences Q4 Earnings Assessment
The earnings results for Sight Sciences (NASDAQ:SGHT) for Q4 were made public o...
03-05 05:48
Earnings Scheduled For March 4, 2026
Companies Reporting Before The Bell • Dingdong (Cayman) (NYSE:DDL) is estimated...
03-04 19:11
Uncovering Potential: Sight Sciences's Earnings Preview
Sight Sciences (NASDAQ:SGHT) is gearing up to announce its quarterly earnings o...
03-04 04:01
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
Stifel Maintains Buy on Sight Sciences, Raises Price Target to $8
Stifel analyst Thomas Stephan maintains Sight Sciences (NASDAQ:SGHT) with a Buy and raises the price target from $6 to $8.
03-03 01:44
Sight Sciences shares are trading lower. The company announced preliminary Q4 and FY25 financial highlights.
Sight Sciences shares are trading lower. The company announced preliminary Q4 a...
01-14 03:36
Sight Sciences Expects Q4 Total Revenue To Be $20.3M-$20.4M And FY25 Revenue To Be $77.3M- $77.4M
Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve
01-13 20:15
